NITHIODOTE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Jan 14, 2011

   15 yr 8 mo ago

2. Today

3. Patent 11753301 expires

   Listed drug substance patent expiration.

   Feb 10, 2030

   in 3 yr 8 mo

4. Patent 12304813 expires

   Listed drug product patent expiration.

   Feb 10, 2030

   in 3 yr 8 mo

5. Patent 9687506 expires

   Listed drug product patent expiration.

   Feb 10, 2030

   in 3 yr 8 mo

6. Patent 9687506 expires

   Listed drug product patent expiration.

   Feb 10, 2030

   in 3 yr 8 mo

7. Patent 10479686 expires

   Listed drug product patent expiration.

   Jul 07, 2030

   in 4 yr 1 mo

8. Patent 9345724 expires

   Listed drug substance patent expiration.

   Jul 07, 2030

   in 4 yr 1 mo

9. Patent 9585912 expires

   Listed drug substance patent expiration.

   Jul 07, 2030

   in 4 yr 1 mo

10. Patent 8496973 expires

    Listed drug substance patent expiration.

    Mar 29, 2031

    in 4 yr 10 mo

11. Patent 8568793 expires

    Listed drug substance patent expiration.

    Dec 24, 2031

    in 5 yr 7 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (9)